1. Home
  2. MEG vs EVO Comparison

MEG vs EVO Comparison

Compare MEG & EVO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Montrose Environmental Group Inc.

MEG

Montrose Environmental Group Inc.

HOLD

Current Price

$24.71

Market Cap

943.9M

ML Signal

HOLD

Logo Evotec SE

EVO

Evotec SE

HOLD

Current Price

$3.11

Market Cap

1.1B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
MEG
EVO
Founded
2012
1993
Country
United States
Germany
Employees
N/A
N/A
Industry
Professional Services
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
943.9M
1.1B
IPO Year
2020
2021

Fundamental Metrics

Financial Performance
Metric
MEG
EVO
Price
$24.71
$3.11
Analyst Decision
Buy
Strong Buy
Analyst Count
4
1
Target Price
$33.50
$7.00
AVG Volume (30 Days)
338.1K
250.1K
Earning Date
11-04-2025
11-05-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$826,323,000.00
$887,396,457.00
Revenue This Year
$19.70
N/A
Revenue Next Year
$2.82
$8.52
P/E Ratio
N/A
N/A
Revenue Growth
22.77
N/A
52 Week Low
$10.51
$2.84
52 Week High
$32.00
$4.80

Technical Indicators

Market Signals
Indicator
MEG
EVO
Relative Strength Index (RSI) 39.77 48.75
Support Level $25.63 $3.03
Resistance Level $26.43 $3.18
Average True Range (ATR) 0.95 0.08
MACD -0.12 0.03
Stochastic Oscillator 0.68 72.58

Price Performance

Historical Comparison
MEG
EVO

About MEG Montrose Environmental Group Inc.

Montrose Environmental Group Inc is an environmental services company. The firm's operating segments are Assessment, Permitting and Response, Measurement and Analysis, and Remediation and Reuse. Through its Assessment, Permitting, and Response segment, the company provides scientific advisory and consulting services to support environmental assessments, environmental emergency response, and environmental audits. Measurement and Analysis include test and analysis of air, water, and soil to determine concentrations of contaminants whereas, the Remediation and Reuse segment provide clients with engineering, design, implementation, operations and maintenance services, to treat contaminated water, remove contaminant or create biogas. United States Contributes the majority of geographic revenue.

About EVO Evotec SE

Evotec is a drug discovery partnership firm providing solutions to pharmaceutical and biotechnology companies, academic institutions, foundations, and nonprofit organizations. The company offers services in a variety of therapeutic areas, including central nervous system disorders, diabetes, inflammation, oncology, infectious diseases, and women's health. The shared R&D segment, roughly 80% of sales, provides drug discovery and manufacturing services on a typical fee-for-service basis and integrated drug discovery collaborations based on its proprietary, internally developed assets. The Just-Evotec Biologics segment, about 20% of sales, offers CDMO services for biologics. As of 2023, the company has over 5,000 employees and 18 production sites mainly in Europe and the United States.

Share on Social Networks: